ACADIA Pharmaceuticals, Inc. (ACAD)
29.63
+0.13
(+0.44%)
USD |
NASDAQ |
Aug 24, 16:00
29.63
0.00 (0.00%)
After-Hours: 19:20
ACADIA Pharmaceuticals Debt to Equity Ratio : 0.0565 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0565 |
| March 31, 2026 | 0.0407 |
| December 31, 2025 | 0.0425 |
| September 30, 2025 | 0.0598 |
| June 30, 2025 | 0.0685 |
| March 31, 2025 | 0.0732 |
| December 31, 2024 | 0.071 |
| September 30, 2024 | 0.0855 |
| June 30, 2024 | 0.1116 |
| March 31, 2024 | 0.1285 |
| December 31, 2023 | 0.1325 |
| September 30, 2023 | 0.1578 |
| June 30, 2023 | 0.1487 |
| March 31, 2023 | 0.162 |
| December 31, 2022 | 0.1548 |
| September 30, 2022 | 0.148 |
| June 30, 2022 | 0.1465 |
| March 31, 2022 | 0.1448 |
| December 31, 2021 | 0.1191 |
| September 30, 2021 | 0.1161 |
| June 30, 2021 | 0.118 |
| March 31, 2021 | 0.1146 |
| December 31, 2020 | 0.079 |
| September 30, 2020 | 0.0751 |
| June 30, 2020 | 0.0126 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0141 |
| December 31, 2019 | 0.014 |
| September 30, 2019 | 0.0149 |
| June 30, 2019 | 0.0287 |
| March 31, 2019 | 0.0268 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Incyte Corp. | 0.006 |
| Agios Pharmaceuticals, Inc. | 0.0304 |
| Biogen, Inc. | 0.4433 |
| Insmed, Inc. | 0.9865 |
| Vertex Pharmaceuticals, Inc. | 0.0977 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.743B |
| Total Liabilities (Quarterly) | 436.29M |
| Shareholders Equity (Quarterly) | 1.307B |
| Current Ratio | 3.388 |
| Net Debt Paydown Yield | -0.08% |